Agency Information Collection Request; 60-Day Public Comment Request, 31509-31510 [2023-10490]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 95 / Wednesday, May 17, 2023 / Notices
130.17), we issued a temporary permit
to Bongards Creameries, 250 Lake Drive
East, Chanhassen, MN 55317, to market
test products that deviate from the
standards of identity for cheese
products under §§ 133.167, 133.169,
133.170, and 133.173 (21 CFR 133.167,
133.169, 133.170, and 133.173) (85 FR
80118, December 11, 2020). We issued
the permit to facilitate market testing of
products that deviate from the
requirements of the standard of identity
for cheese products issued under
section 401 of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 341). The
permit covers limited interstate
marketing tests of cheese products.
The test products deviate from the
standards of identity for cheese
products under §§ 133.167, 133.169,
133.170, and 133.173. For the purpose
of this permit, natamycin, which is not
permitted under the standards of
identity for these cheese products,
would be added as a mold inhibitor in
the standardized cheeses. The inhibitor
would be incorporated into blended and
processed cheese just prior to
pasteurization and further cast into
slices (or packaging into loaves or other
final forms as in the case of pasteurized
process cheese spread). Natamycin,
which is stable under typical thermal
processing conditions for pasteurized
cheeses, would be added directly to
cheese blends just prior to
pasteurization, as is done with other
mold inhibitors such as sorbic acid,
sodium propionate, and their approved
variants. The final concentration of
natamycin would not exceed 20 parts
per million and would be effective at
producing process and blended slices
with a shelf life of up to 150 days before
seeing mold growth.
The test products meet all the
requirements of the standard with the
exception of this deviation.
On December 22, 2022, the applicant
asked us to extend the temporary permit
so the applicant could have more time
to market test the cheese products and
gain additional consumer acceptance in
support of the petition to amend the
standard for cheese products. We find
that it is in the interest of consumers to
extend the permit for continued market
testing of the cheese products to gain
additional information on consumer
expectations and acceptance. Therefore,
under § 130.17(i), we are extending the
temporary permit granted to Bongards
Creameries for temporary marketing of a
maximum of 100 million pounds
(45,359,237 kilograms) of cheese
products to provide continued market
testing of the specified amount of
product for the applicant on an annual
basis. The new expiration date of the
VerDate Sep<11>2014
18:34 May 16, 2023
Jkt 259001
permit will be either the effective date
of a final rule amending the standard of
identity for cheese products that may
result from the petition or 30 days after
denial of the petition. All other
conditions and terms of this permit
remain the same.
In addition, we invite interested
persons to participate in the market test
under the conditions of the permit,
except for the designated area of
distribution. Any person who wishes to
participate in the extended market test
must notify, in writing, the Branch
Chief, Product Evaluation Labeling
Branch, Division of Food Labeling and
Standards, Office of Nutrition and Food
Labeling, Center for Food Safety and
Applied Nutrition, via
FDAFoodsProgramTMP@fda.hhs.gov.
The notification must describe the test
products and the area of distribution,
specify and justify the amount
requested, and include the labeling that
will be used for the test product (i.e., a
draft label for each size of container and
each brand of product to be market
tested) (see § 130.17(c)). The
information panels on the labels of the
test products must bear nutrition
labeling in accordance with 21 CFR
101.9. Each of the ingredients used in
the food must be declared on the label
as required by 21 CFR part 101.
Dated: May 10, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–10438 Filed 5–16–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0990-new]
Agency Information Collection
Request; 60-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before July 17, 2023.
ADDRESSES: Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 264–0041 and PRA@HHS.GOV.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0990–New–60D
SUMMARY:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
31509
and project title for reference, to
Sherrette A. Funn, email:
Sherrette.Funn@hhs.gov, PRA@
HHS.GOV or call (202) 264–0041 the
Reports Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Critical
Infrastructure Protection Healthcare and
Public Health (HPH) Partnership Data
Collection.
Type of Collection: NEW.
OMB No.: 0990–new.
Abstract: The Administration for
Strategic Preparedness and Response’s
(ASPR) Office of Critical Infrastructure
Protection (CIP) serves as the (HPH)
Sector Risk Management Agency
(SRMA) designee on behalf of the
Department of Health and Human
Services (HHS) as codified by the 2021
National Defense Authorization Act
(NDAA), supporting the HPH Sector to
prepare for future threats, manage risks,
coordinate effective response, and
recover from human-caused and
naturally occurring threats and hazards.
CIP promotes resilience of the
nation’s health critical infrastructure by
working directly with public and
private sector partners to establish risk
assessment tools, foster information
sharing, provide technical resources and
assistance, and lead programs to prepare
for, respond to, and recover from
human-caused and naturally occurring
threats and hazards. CIP specifically
manages the (HPH) Sector Critical
Infrastructure Protection Partnership
(HPH Partnership), a coordinating body
of more than 300 private sector
organizations and federal and state,
tribal, local, and territorial (STLT)
government entities. CIP relies on a
strong partnership federal and STLT
government entities through the
Government Coordinating Council
(GCC) and with critical infrastructure
owners and operators through the
private Sector Coordinating Council
(SCC). Together, the councils of the
HPH Partnership form a private-public
network that promotes situational
awareness, coordination, capacity-
E:\FR\FM\17MYN1.SGM
17MYN1
31510
Federal Register / Vol. 88, No. 95 / Wednesday, May 17, 2023 / Notices
building, and preparedness and
response capabilities by fostering a
shared understanding of Sector risks,
needs, and opportunities.
SRMAs are expected to determine the
extent to which their respective sectors
are implementing infrastructure
protection frameworks and guidance
(e.g., cybersecurity). Per the 2013
National Infrastructure Protection Plan
(NIPP), they ‘‘serve as a day-to-day
Federal interface for the dynamic
prioritization and coordination of
sector-specific activities and carry out
incident management responsibilities’’.
CIP’s success as the SRMA depends
heavily on routine and ad hoc data to
inform its programs and activities in the
HPH Sector.
CIP plans to collect data bi-annually
to understand the impact of the HPH
Partnership’s work on HPH Sector
resilience. Using survey-based data
collection tools, CIP will measure the
performance of the HPH Partnership as
a program and use the resulting
information to assess the Office’s
responsiveness to its statutory
responsibilities, including those
articulated in Section 2009(b) in the
2021 NDAA. The data will additionally
support CIP’s ability to improve
programmatic operations and inform
decision-making. CIP will also collect
data under urgent circumstances to
guide emergency response activities and
after-action reporting for the HPH
Sector.
ANNUALIZED BURDEN HOUR TABLE
HPH Partnership Bi-Annual Survey Collection (Fall).
HPH Partnership Bi-Annual Survey Collection (Spring).
Ad hoc Information Collections .................
HPH Partnership Members ......
308
1
15/60
77
HPH Partnership Members ......
308
1
15/60
77
HPH Partnership Members ......
308
1
1
308
Total ...................................................
..................................................
........................
3
........................
462
[FR Doc. 2023–10490 Filed 5–16–23; 8:45 am]
BILLING CODE 4150–37–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Advisory Committee on
Blood and Tissue Safety and
Availability
index.html when this information
becomes available.
FOR FURTHER INFORMATION CONTACT:
James Berger, Designated Federal Officer
for the ACBTSA; Office of Infectious
Disease and HIV/AIDS Policy, Office of
the Assistant Secretary for Health,
Department of Health and Human
Services, Tower Building, 1101 Wootton
Parkway, Rockville, MD 20852. Email:
ACBTSA@hhs.gov. Phone: 202–795–
7608.
On the
day of the meeting, please go to https://
www.hhs.gov/live/ to view
the meeting. The public will have an
opportunity to present their views to the
ACBTSA by submitting a written public
comment. Comments should be
pertinent to the meeting discussion.
Persons who wish to provide written
public comment should review
instructions at https://www.hhs.gov/
oidp/advisory-committee/blood-tissuesafety-availability/meetings/2023-07-06/
index.html and respond by midnight
June 28, 2023, ET. Written public
comments will be accessible to the
public on the ACBTSA web page prior
to the meeting.
Background and Authority: The
ACBTSA is a discretionary Federal
advisory committee and is governed by
the provisions of the Federal Advisory
Committee Act (FACA), Public Law 92–
463, as amended (5 U.S.C. app), which
sets forth standards for the formation
and use of advisory committees. The
ACBTSA functions to provide advice to
the Secretary through the Assistant
SUPPLEMENTARY INFORMATION:
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
AGENCY:
ACTION:
Notice.
The U.S. Department of
Health and Human Services is hereby
giving notice that the Advisory
Committee on Blood and Tissue Safety
and Availability (ACBTSA) will hold a
meeting. The meeting will be open to
the public via webcast. The committee
will discuss and vote on a
recommendation related to surge
capacity for blood and blood products.
SUMMARY:
The meeting will take place on
July 6–7, 2023 from approximately 10
a.m.–3 p.m. Eastern Time (ET) each day.
Meeting times are tentative and subject
to change. The confirmed times and
agenda items for the meeting will be
posted on the ACBTSA web page at
https://www.hhs.gov/oidp/advisorycommittee/blood-tissue-safetyavailability/meetings/2023-07-06/
DATES:
ddrumheller on DSK120RN23PROD with NOTICES1
Average
burden per
response
Respondents
(if necessary)
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
Number of
respondents
Number of
responses per
respondents
Forms
(if necessary)
VerDate Sep<11>2014
18:34 May 16, 2023
Jkt 259001
PO 00000
Frm 00033
Fmt 4703
Sfmt 9990
Total burden
hours
Secretary for Health on a range of policy
issues to include: (1) Identification of
public health issues through
surveillance of blood and tissue safety
issues with national survey and data
tools; (2) identification of public health
issues that affect availability of blood,
blood products, and tissues; (3) broad
public health, ethical, and legal issues
related to the safety of blood, blood
products, and tissues; (4) the impact of
various economic factors (e.g., product
cost and supply) on safety and
availability of blood, blood products,
and tissues; (5) risk communications
related to blood transfusion and tissue
transplantation; and (6) identification of
infectious disease transmission issues
for blood, organs, blood stem cells and
tissues. The Committee has met
regularly since its establishment in
1997.
Dated: May 2, 2023.
James J. Berger,
Designated Federal Officer, Advisory
Committee on Blood and Tissue Safety and
Availability, Office of Infectious Disease and
HIV/AIDS Policy.
[FR Doc. 2023–10499 Filed 5–16–23; 8:45 am]
BILLING CODE 4150–28–P
E:\FR\FM\17MYN1.SGM
17MYN1
]]>Agencies
[Federal Register Volume 88, Number 95 (Wednesday, May 17, 2023)]
[Notices]
[Pages 31509-31510]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-10490]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier: OS-0990-new]
Agency Information Collection Request; 60-Day Public Comment
Request
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995, the Office of the Secretary (OS), Department of Health and
Human Services, is publishing the following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be received on or before July 17, 2023.
ADDRESSES: Submit your comments to [email protected] or by calling
(202) 264-0041 and [email protected].
FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting
information, please include the document identifier 0990-New-60D and
project title for reference, to Sherrette A. Funn, email:
[email protected], [email protected] or call (202) 264-0041 the Reports
Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
Title of the Collection: Critical Infrastructure Protection
Healthcare and Public Health (HPH) Partnership Data Collection.
Type of Collection: NEW.
OMB No.: 0990-new.
Abstract: The Administration for Strategic Preparedness and
Response's (ASPR) Office of Critical Infrastructure Protection (CIP)
serves as the (HPH) Sector Risk Management Agency (SRMA) designee on
behalf of the Department of Health and Human Services (HHS) as codified
by the 2021 National Defense Authorization Act (NDAA), supporting the
HPH Sector to prepare for future threats, manage risks, coordinate
effective response, and recover from human-caused and naturally
occurring threats and hazards.
CIP promotes resilience of the nation's health critical
infrastructure by working directly with public and private sector
partners to establish risk assessment tools, foster information
sharing, provide technical resources and assistance, and lead programs
to prepare for, respond to, and recover from human-caused and naturally
occurring threats and hazards. CIP specifically manages the (HPH)
Sector Critical Infrastructure Protection Partnership (HPH
Partnership), a coordinating body of more than 300 private sector
organizations and federal and state, tribal, local, and territorial
(STLT) government entities. CIP relies on a strong partnership federal
and STLT government entities through the Government Coordinating
Council (GCC) and with critical infrastructure owners and operators
through the private Sector Coordinating Council (SCC). Together, the
councils of the HPH Partnership form a private-public network that
promotes situational awareness, coordination, capacity-
[[Page 31510]]
building, and preparedness and response capabilities by fostering a
shared understanding of Sector risks, needs, and opportunities.
SRMAs are expected to determine the extent to which their
respective sectors are implementing infrastructure protection
frameworks and guidance (e.g., cybersecurity). Per the 2013 National
Infrastructure Protection Plan (NIPP), they ``serve as a day-to-day
Federal interface for the dynamic prioritization and coordination of
sector-specific activities and carry out incident management
responsibilities''. CIP's success as the SRMA depends heavily on
routine and ad hoc data to inform its programs and activities in the
HPH Sector.
CIP plans to collect data bi-annually to understand the impact of
the HPH Partnership's work on HPH Sector resilience. Using survey-based
data collection tools, CIP will measure the performance of the HPH
Partnership as a program and use the resulting information to assess
the Office's responsiveness to its statutory responsibilities,
including those articulated in Section 2009(b) in the 2021 NDAA. The
data will additionally support CIP's ability to improve programmatic
operations and inform decision-making. CIP will also collect data under
urgent circumstances to guide emergency response activities and after-
action reporting for the HPH Sector.
Annualized Burden Hour Table
----------------------------------------------------------------------------------------------------------------
Number of
Forms (if necessary) Respondents (if Number of responses per Average burden Total burden
necessary) respondents respondents per response hours
----------------------------------------------------------------------------------------------------------------
HPH Partnership Bi-Annual HPH Partnership 308 1 15/60 77
Survey Collection (Fall). Members.
HPH Partnership Bi-Annual HPH Partnership 308 1 15/60 77
Survey Collection (Spring). Members.
Ad hoc Information Collections HPH Partnership 308 1 1 308
Members.
---------------------------------------------------------------
Total..................... ................ .............. 3 .............. 462
----------------------------------------------------------------------------------------------------------------
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance Officer, Office of the
Secretary.
[FR Doc. 2023-10490 Filed 5-16-23; 8:45 am]
BILLING CODE 4150-37-P
